Biggest News Aggregation in the World
๐Ÿ“ฐ Human Use News

Page 133 - Human Use News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.

BioMarin Pharmaceutical Inc.: BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A

European Commission Approval Expected Q3 2022 First Gene Therapy for Treatment of Hemophilia A Recommended for Approval in Europe More than 20,000 Adults with Severe, Hemophilia
Nordrhein Westfalen Hank Fuchs Johannes Oldenburg University Clinic In Bonn European Commission Biomarin Pharmaceutical Inc

Investegate |Formycon AG Announcements | Formycon AG: FYB201, Formycon's biosimilar for Lucentis® (ranibizumab), receives CHMP recommendation from EMA

Investegate announcements from Formycon AG, FYB201, Formycons biosimilar for Lucentisยฎ (ranibizumab), receives CHMP recommendation from EMA
European Commission Genentech Inc Teva Pharmaceutical Industries Ltd European Union Corporate Communications Market Scale Of The Frankfurt Stock Exchange

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Kyowa Kirin Co., Ltd.: Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA (burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of tumours Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that
Scottish Borders United Kingdom United States Great Britain Stacey Minton Abdul Mullick

Oncopeptides AB: CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma

STOCKHOLM, June 23, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological
United Kingdom Oncopeptides Pepaxti Annika Muskantor Rolf Gulliksen Klaas Bakker Pieter Sonneveld

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science